Director Dean Alan Buys 907 DSUs in PERPETUA RESOURCES, Signaling Bullish Confidence Amid Antimony Buzz

Insider Activity Spotlight: Dean Robert Alan’s Recent Purchase in PERPETUA RESOURCES CORP

On September 25 2026, director Dean Robert Alan added 907 Deferred Share Units (DSUs) to his holdings, bringing the total to 69,679 units at an average price of $23.42. The transaction, filed under Form 4, was executed at the current market price of $23.49, matching the closing price on September 23. With a weekly gain of 1.08% and a modest yearly rise of 14.03%, the stock’s momentum is steady, but the company still faces a negative P/E of –12.56 and a 52‑week low near $16.44. Alan’s purchase, occurring amid a 384 % surge in social‑media buzz, signals confidence that the company’s antimony exploration in Idaho may soon generate tangible value.

Implications for Investors and the Company’s Outlook

Alan’s DSU purchase is a bullish signal that may assuage skepticism about the viability of a still‑exploratory stibnite‑antimony project. DSUs convert into common shares only after vesting, providing the director with a longer‑term commitment that aligns his interests with shareholders. The timing—just after a modest weekly gain—suggests confidence that the upcoming regulatory and supply‑chain developments could lift the stock further. For investors, this could reduce the perceived risk premium on the stock and support a higher valuation, especially as the company’s project moves closer to feasibility studies or production.

However, the negative earnings and high market cap relative to cash flow remind analysts that the company remains a speculative play. The insider activity may prompt analysts to reassess the discount rate applied to future cash flows, potentially tightening the valuation range but also highlighting the importance of the project’s success in driving a turnaround.

Dean Robert Alan: A Profile of Commitment and Caution

Alan’s transaction history paints the picture of a cautious yet steadily accumulating insider. Since December 2025, he has made a series of DSU purchases (e.g., 483 units on 2025‑12‑23, 1,006 units on 2026‑06‑25) while intermittently buying and selling common shares. Notably, his common‑share activity is largely “sell” oriented in early 2026, indicating a strategy of liquidity management rather than speculative flipping. The repeated DSU purchases—often at prices slightly above the market average—signal a long‑term stake, consistent with his role as a director who values the company’s strategic direction over short‑term gains.

Alan’s pattern also shows a preference for deferred incentives that vest over time, reducing the risk of market timing and aligning his incentives with the company’s long‑term performance. This approach has earned him a reputation among peers for prudent capital allocation and a commitment to the company’s core mission of developing critical materials.

What It Means for PERPETUA’s Future

The convergence of a director’s DSU accumulation, a solid yet modest stock performance, and a high social‑media buzz around the company’s antimony project suggests that the market is beginning to recognize the strategic significance of the Idaho deposit. If the project proceeds past feasibility and into early production, it could unlock a new revenue stream that would dramatically improve the company’s cash flow profile, turning the current negative P/E into a sustainable, positive earnings trajectory.

Until then, investors should view Alan’s DSU purchase as a vote of confidence rather than a guarantee of imminent upside. It does, however, provide a useful benchmark for assessing insider sentiment and may serve as a catalyst for further institutional interest, potentially supporting the stock’s upward trajectory in the months ahead.